Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study.

Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study.

Item
http://www.wikidata.org/entity/Q48283864
Sucralose, a synthetic organochlorine sweetener: overview of biological issuesMetabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations.Contribution of tumoral and host solute carriers to clinical drug response.Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewTherapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.Interactions between oral antineoplastic agents and concomitant medication: a systematic review.Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients.Pharmacokinetic Aspects of Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors.Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions.Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy.Microarray Analysis of Differentially-Expressed Genes Encoding CYP450 and Phase II Drug Metabolizing Enzymes in Psoriasis and Melanoma.Evaluation of Time Dependent Inhibition Assays for Marketed Oncology Drugs: Comparison of Human Hepatocytes and Liver Microsomes in the Presence and Absence of Human Plasma.
P2860

Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study.

Item
http://www.wikidata.org/entity/Q48283864
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Interaction of sorafenib and c ...... macokinetic interaction study.
@en
Interaction of sorafenib and c ...... macokinetic interaction study.
@nl
type
label
Interaction of sorafenib and c ...... macokinetic interaction study.
@en
Interaction of sorafenib and c ...... macokinetic interaction study.
@nl
prefLabel
Interaction of sorafenib and c ...... macokinetic interaction study.
@en
Interaction of sorafenib and c ...... macokinetic interaction study.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Interaction of sorafenib and c ...... macokinetic interaction study.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698